NCT06426771

Brief Summary

The aim of the study was to calculate the dietary inflammatory index, dietary phytochemical index and NRF nutrient density of the dietary pattern routinely consumed by women and to assess whether there is a difference between PCOS patients with high AMH levels and the group with low AMH levels.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 23, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

September 20, 2024

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2024

Completed
Last Updated

November 19, 2024

Status Verified

November 1, 2024

Enrollment Period

11 days

First QC Date

May 18, 2024

Last Update Submit

November 16, 2024

Conditions

Keywords

NRF Nutrient Density IndexDietary Inflammatory IndexPhytochemical Indexanti-Müllerian hormone

Outcome Measures

Primary Outcomes (1)

  • AMH levels according to dietary indexes

    Patients with low, normal and high AMH values are examined for differences in the indices calculated according to nutrient density.

    6 months

Study Arms (3)

Low AMH Levels-

AMH levels: those with low AMH levels (\<1.2 ng/ml): 30 participants

Behavioral: Dietary Inflammatory IndexDiagnostic Test: hormone profile

Normal AMH levels-

normal AMH levels (1.2-3.32 ng/ml): 30 participants

Behavioral: Dietary Inflammatory IndexDiagnostic Test: hormone profile

High AMH levels-

high AMH levels (\>3.32 ng/ml): 30 Participants

Behavioral: Dietary Inflammatory IndexDiagnostic Test: hormone profile

Interventions

The aim of this study was to compare the dietary habits of patients with PCOS and an AMH value of \>3.32 ng/ml, of patients with low ovarian reserve without PCOS and an AMH value of less than 1.2 ng/ml and of patients with normal AMH values (between 1.2-3.32 ng/ml) according to Dietary Nutrient Density according to Dietary Inflammatory Index, Dietary Phytochemical Index and Nutrient Rich Food Index.

Also known as: Dietary Phytochemical Index, Nutrient Rich Food Index
High AMH levels-Low AMH Levels-Normal AMH levels-
hormone profileDIAGNOSTIC_TEST

In the routine practice of the PCOS clinic, about 7 ml of blood is taken in a vacuum gel tube for hormonal and biochemical analysis by medical staff. The blood samples are centrifuged by the researchers at 1000xg for 20 minutes. In the next step, the supernatant part is separated and transferred to 3 mL Ependorfs. These samples are used to determine the levels of anti-Müllerian hormone (AMH), oestradiol, LH and FSH, which are routinely determined at the PCOS clinic.

High AMH levels-Low AMH Levels-Normal AMH levels-

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

This study was designed as a cross-sectional cohort study including individuals who were followed up in the PCOS Clinic and dietetic department of Etlik Zübeyde Hanım Gynaecology Training and Research Hospital. Patients will be divided into 3 groups according to AMH value as those with low AMH value, those with normal AMH value and those with high AMH value (11). The study will include 90 individuals who agreed to be included in the study and accepted the consent form verbally and in writing.

You may qualify if:

  • Between the ages of 18 and 40,
  • No underlying metabolic disease (type 2 diabetes, hypertension, diagnosed anemia),
  • Female patients with AMH levels in our hospital,
  • Participants attending the PCOS clinic and under the care of our hospital dietitian will be enrolled in the study.

You may not qualify if:

  • Age \< 18 and \> 40 years;
  • Menopause, pregnancy or breastfeeding in the last 6 months;
  • Hyperandrogenism and/or biochemical hyperandrogenemia due to secondary causes, including congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, thyroid dysfunction, and adrenal disease),
  • Pre-existing systemic or psychiatric illnesses
  • Taking medication that affects carbohydrate or fat metabolism (contraceptive pills, metformin, antiepileptic drugs, antipsychotics, statins and fish oil);
  • Certain nutritional therapies or hypocaloric diet in the last three months; supplementation with antioxidants, vitamins or minerals;
  • Taking medications that can affect fluid balance, such as non-steroidal anti-inflammatory drugs, diuretics, etc.
  • Female patients with implanted pacemakers or defibrillators due to the theoretical possibility of impaired device activity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Etlik Zübeyde Hanım

Ankara, 06000, Turkey (Türkiye)

Location

Related Publications (2)

  • Lakoma K, Kukharuk O, Sliz D. The Influence of Metabolic Factors and Diet on Fertility. Nutrients. 2023 Feb 27;15(5):1180. doi: 10.3390/nu15051180.

    PMID: 36904180BACKGROUND
  • Barrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C, Pugliese G, Colao A, Savastano S. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients. 2019 Sep 23;11(10):2278. doi: 10.3390/nu11102278.

MeSH Terms

Conditions

Feeding BehaviorPolycystic Ovary Syndrome

Condition Hierarchy (Ancestors)

Behavior, AnimalBehaviorOvarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Study Officials

  • Mujde Can Ibanoglu

    Ankara Etlik Zubeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof

Study Record Dates

First Submitted

May 18, 2024

First Posted

May 23, 2024

Study Start

September 20, 2024

Primary Completion

October 1, 2024

Study Completion

November 10, 2024

Last Updated

November 19, 2024

Record last verified: 2024-11

Locations